Authors


Amy Emerson
Amy Emerson

Latest:

MDMA-Assisted Therapy for PTSD: A Conversation With Amy Emerson, CEO of Lykos Therapeutics

If approved, how will MDMA-assisted therapy impact clinical psychiatry? The CEO of Lykos Therapeutics shares her thoughts.


Aaron Mack, MD

Latest:

Recognizing the Contributions and the Struggles of Black Psychiatrists

“It is of the utmost importance to provide culturally competent forensic psychiatric services that are better suited to the needs of the African American community.”


Justin S. Tauscher, PhD

Latest:

Integrating Digital Therapeutics Into Care of Serious Mental Illness

How can digital therapeutics more readily be brought into the hands of patients with serious mental illnesses?




Douglas W. Heinrichs, MD

Latest:

Medical Aid in Dying and the “Slippery Slope” Argument

An expert offers a critical examination of the "slippery slope" argument.


Amit Etkin, MD, PhD

Latest:

Mapping the Mind

How can we enhance our understanding of the human brain?


Ekta Patel, PhD

Latest:

Driving Advances in Drug Discovery for Mental Health Conditions

Understanding and addressing the unmet therapeutic needs of individuals living with mental health conditions.


Jun Park

Latest:

Dietary Interventions for ADHD: Emerging Research and Considerations

What is the connection between ADHD diagnosis and a Western dietary pattern?


Warren Y.K. Ng, MD, MPH

Latest:

The Urgent Need to Address Youth Mental Health

In this 2-part Special Report, we highlight the urgency of addressing child and adolescent mental health.


Alejandro Alva, MD

Latest:

The Cutting Edge of Medicine: An Interview With Alejandro Alva, MD

In advance of the June 4 FDA Advisory Committee Meeting on MDMA-assisted therapy, we sat down with Alejandra Alva, MD, to get his first impressions.


Rosemary Kennedy, PhD

Latest:

The Role of Technology in Addressing Isolation of Older Adults

Seniors living independently have suffered isolation during the pandemic. What role can technology play in solving this?


Sarah J. Getz, PhD

Latest:

Vulnerability to Financial Scamming: Victim and Family Protection

With the growing elderly population and the prevalence of cognitive impairment, how can we protect older adults from financial scams?


Victor Ajluni, MD

Latest:

Cannabis and Schizophrenia: Implications in the Legalization Era

A look at the association between cannabis use and schizophrenia, as well as the need for comprehensive public health policies and education.


Marie Anne Gebara, MD

Latest:

Augmentation Strategies for Treatment-Resistant Depression

Given that two-thirds of patients treated for a major depressive episode will fail to achieve remission of symptoms after 2 or more treatment trials of first-line antidepressants, the probability of remission will further decrease with subsequent medication trials. Treatment strategies for patients with TRD include augmentation, where a medication is added to a current antidepressant versus switching to a different antidepressant.


Alan Schwartz, MD

Latest:

Psychiatrists Call for End to Cruel and Harmful Immigration Policy

The Group for the Advancement of Psychiatry (America’s mental health think tank) calls for an end to the use of Title 42 to expel asylum seekers at the southern border. This policy places LGBTIQ asylum seekers in particular danger.


Robin M. Johnson, MD

Latest:

The Vanishing White Coat

If Roe v Wade is overturned, how will patients with serious mental illness be affected?



Sara Wetzler

Latest:

The Faces of Madness

If a picture is worth a thousand words, how many diagnoses can it make? The photographer and psychiatrist Hugh Welch Diamond, MD, shares insights into the humanity and stigma of mental illness in Victorian England.


Nayana Kunnel, DO

Latest:

Exploring Vital Amines: The Who, What, When, Where, Why, and How of B12 Deficiency

Key nutrients are essential to maintaining health. Here's an overview of B12.



Albert Stuart Reece, MBBS, FRCS, FRCS, FRACGP, MD

Latest:

Cannabis in Pregnancy – Rejoinder, Exposition and Cautionary Tales

Cannabis use during pregnancy is associated with a host of negative outcomes.


Catherine Lanteri, MD

Latest:

Developing Your Skills at the Intersection of Work and Psychiatry

Here’s how the Academy of Organizational and Occupational Psychiatry can help you connect with your fellow psychiatrists about complex mental health issues in the workplace.


Jia Pamela Guo, MD Candidate 2021

Latest:

When Oaths Are Broken: A Call to Action

The medical community must examine how and what we can do to welcome and serve the black and brown communities that may view us as the authority they dare not call.


Tonya Cross Hansel, PhD, LMSW

Latest:

Suicide Prevention and COVID-19's Impact

Issues of well-being, especially during a disaster or pandemic, are not going to disappear. Dr Cross Hansel talks suicide prevention week and how to get patients back to their pre-pandemic mental health state.


H. Edmund Pigott, PhD

Latest:

STAR*D’s Cumulative Remission Rate and Why It Still Matters

Contesters of STAR*D discuss the impact and relevance of the study's remission rates.


Nichole D. Olson, PhD

Latest:

Opening Pandora’s Box: The Importance of Assessing and Treating Trauma in Individuals Experiencing Psychosis

Traumatic life events are common among individuals who experience psychosis. Here's how best to assess and treat.


Michael Ashley Stein, PhD, JD

Latest:

Restorative Justice vs Hate Speech

How can we prevent retraumatization of vulnerable individuals and enable them to seek redress?


Aisha O. Adigun, MD

Latest:

Medication Modification Equivalent for Virtual and In-Person Psychiatric Visits

Mental health leads with 36% of all outpatient visits and 39% of all telehealth services. What effect does this have on psychiatric practice?


© 2024 MJH Life Sciences

All rights reserved.